- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Sodium-GLucose coTransporter-2 Inhibitors
Total 8400 results
-
Loma Linda UniversityCalifornia Walnut CommissionTerminated
-
University of AkureyriWestern Norway University of Applied SciencesCompletedCardiovascular Risk Factor | Primary Health Care | Pre-diabetes | T2DM (Type 2 Diabetes Mellitus)Iceland
-
Pharvaris Netherlands B.V.Active, not recruitingHereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditionsUnited States, Poland, Germany, Austria, Bulgaria, Canada, Ireland, Italy, United Kingdom
-
Chinese PLA General HospitalUnknown
-
Foundation for the National Institutes of HealthEli Lilly and Company; National Institute of Diabetes and Digestive and Kidney... and other collaboratorsCompleted
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul; Coordenação de Aperfeiçoamento de...CompletedDiabetes Mellitus Type 2 | Dietary Modification | Insulin Tolerance | Diabetic Blood Glucose MonitoringBrazil
-
National Institute of Diabetes and Digestive and...CompletedObesity | Diabetes Mellitus, Type 2 | Type 2 Diabetes | Abnormal Glucose MetabolismUnited States
-
Jeil Pharmaceutical Co., Ltd.Not yet recruitingType 2 Diabetes MellitusKorea, Republic of
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Sun Yat-sen UniversityGuangdong Provincial Hospital of Traditional Chinese Medicine; The Third Affiliated... and other collaboratorsRecruitingType 2 Diabetes MellitusChina
-
BayerActive, not recruiting
-
Shanghai HEP Pharmaceutical Co., Ltd.WithdrawnType 2 Diabetes Patients
-
Nanjing First Hospital, Nanjing Medical UniversityActive, not recruitingType 2 Diabetes MellitusChina
-
Rush University Medical CenterWithdrawn
-
TheracosCompletedType 2 Diabetes MellitusGermany, United States, Spain, Poland
-
AstraZenecaCompletedType 2 Diabetes MellitusKorea, Republic of
-
Oramed, Ltd.IntegriumCompletedDiabetes Type 2United States
-
Antonio Di MauroCompletedType-2 DiabetesItaly
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusGermany, United States
-
University of OxfordNIHR Collaboration for Leadership in Applied Health Research and Care (Oxford)CompletedType 2 Diabetes MellitusUnited Kingdom
-
Kun-Ho YoonTakedaCompletedType 2 Diabetes MellitusKorea, Republic of
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
KeyBioscience AGNordic Bioscience A/SCompletedType 2 Diabetes MellitusDenmark, Czechia, Poland, Moldova, Republic of, Romania, United Kingdom
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
University of PalermoAstraZeneca; University of CataniaUnknown
-
LG Life SciencesCompleted
-
Biocon LimitedCompletedType 2 Diabetes Mellitus
-
Sun Yat-sen UniversitySuspended
-
Novartis PharmaceuticalsCompletedType-2 Diabetes MellitusHong Kong
-
Dong-A ST Co., Ltd.CompletedType 2 Diabetes MellitusKorea, Republic of
-
NovartisCompleted
-
TakedaTerminatedType 2 Diabetes MellitusUnited States, Poland, Ukraine, Taiwan, Bulgaria, Romania, Slovakia
-
TakedaCompleted
-
HealthPartners InstituteAmylin Pharmaceuticals, LLC.CompletedType 2 Diabetes MellitusUnited States
-
University of ArizonaUnknownType 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCCompleted
-
Poxel SACompletedType 2 Diabetes MellitusLatvia
-
Pusan National University HospitalUnknownType 2 Diabetes MellitusKorea, Republic of
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Mexico, India
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
Hospital Universitario Central de AsturiasSanofiTerminated
-
Charles Drew University of Medicine and ScienceNational Center for Research Resources (NCRR)Completed
-
Endocrine Research SocietySuspendedType 2 Diabetes MellitusCanada
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusPoland, United Kingdom, Germany, Romania, Hungary, Denmark, Lithuania
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusChina